Keywords: smithkline, copromote, alcar, beecham, sigma-tau, spa, announced

SMITHKLINE TO COPROMOTE ALCAR

Article | 29 June 1992

SmithKline Beecham and Sigma-Tau SpA have announced an agreement to copromote Alcar (acetyl-L-carnitine), a treatment for degenerative disorders of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in